BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38109745)

  • 1. A case of subarachnoid haemorrhage associated with MPO-ANCA-positive eosinophilic granulomatosis with polyangiitis, successfully treated with glucocorticoid, cyclophosphamide, and mepolizumab.
    Satake Y; Sakai S; Takao T; Saeki T
    Mod Rheumatol Case Rep; 2023 Dec; ():. PubMed ID: 38109745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis.
    Moiseev S; Bossuyt X; Arimura Y; Blockmans D; Csernok E; Damoiseaux J; Emmi G; Flores-Suárez LF; Hellmich B; Jayne D; Jennette JC; Little MA; Mohammad AJ; Moosig F; Novikov P; Pagnoux C; Radice A; Sada KE; Segelmark M; Shoenfeld Y; Sinico RA; Specks U; Terrier B; Tzioufas AG; Vaglio A; Zhao MH; Cohen Tervaert JW;
    Am J Respir Crit Care Med; 2020 Jun; ():. PubMed ID: 32584187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan.
    Yamane T; Hashiramoto A
    Arthritis Res Ther; 2023 Jun; 25(1):110. PubMed ID: 37365612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsing subarachnoid hemorrhage as a clinical manifestation in microscopic polyangiitis: a case report and literature review.
    Xie J; Jia E; Wang S; Yu Y; Li Z; Zhang J; Li J
    Clin Rheumatol; 2022 Oct; 41(10):3227-3235. PubMed ID: 35690669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Treatment of Eosinophilic Granulomatosis With Polyangiitis: A Case of Refractory Peripheral Neuropathy and Comorbid Chronic Progressive Pulmonary Aspergillosis Treated With Mepolizumab.
    Sekiya R; Soma T; Nakagome K; Nagata M
    Cureus; 2024 Jan; 16(1):e52192. PubMed ID: 38222984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of eosinophilic granulomatosis with polyangiitis during the clinical course of microscopic polyangiitis: A case report.
    Ide H; Shimizu T; Koike Y; Abe K; Shigematsu K; Nishihata S; Kojima K; Ichinose K; Kawakami A
    Medicine (Baltimore); 2022 Nov; 101(44):e31401. PubMed ID: 36343053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
    Ennis D; Lee JK; Pagnoux C
    Expert Opin Biol Ther; 2019 Jul; 19(7):617-630. PubMed ID: 31146595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report.
    Suzaki I; Tanaka A; Yanai R; Maruyama Y; Kamimura S; Hirano K; Kobayashi H
    BMC Pulm Med; 2023 Apr; 23(1):130. PubMed ID: 37076824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of Chronic Rhinosinusitis and Reduction of the Myeloperoxidase-Antineutrophil Cytoplasmic Antibody Titer in a Patient with Eosinophilic Granulomatosis with Polyangiitis by Additional Mepolizumab.
    Tamechika SY; Isogai S; Maeda S; Naniwa T; Niimi A
    Case Rep Rheumatol; 2021; 2021():5561762. PubMed ID: 33859858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations.
    Watanabe R; Hashimoto M
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review.
    Mutoh T; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
    Rheumatol Int; 2022 Nov; 42(11):2069-2076. PubMed ID: 34287685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.
    Frątczak A; Polak K; Miziołek B; Bergler-Czop B
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):116-118. PubMed ID: 36254546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe eosinophilic granulomatosis with polyangiitis responding to a combination of rituximab and mepolizumab.
    Tsioulos G; Kounatidis D; Vallianou NG; Koufopoulos N; Katsimbri P; Antoniadou A
    Am J Med Sci; 2023 Jan; 365(1):93-98. PubMed ID: 35970248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent Use of Mepolizumab and Rituximab for Eosinophilic Granulomatosis With Polyangiitis and Multisystem Involvement.
    Afiari A; Gabriel A; Gaiki MR
    Cureus; 2020 Jul; 12(7):e9242. PubMed ID: 32821588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort.
    Liu S; Han L; Liu Y; Yang J; Zhang Y; Li M; Tian X; Zeng X; Wang L; Zhang F
    Front Immunol; 2022; 13():885198. PubMed ID: 35833130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis.
    Higashitani K; Yoshimi R; Sato Y; Watanabe T; Ihata A
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):87-92. PubMed ID: 34473835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on eosinophilic granulomatosis with polyangiitis.
    Furuta S; Iwamoto T; Nakajima H
    Allergol Int; 2019 Oct; 68(4):430-436. PubMed ID: 31266709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Treatment With Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A Case Report.
    Toscano Peña A; Ali Munive A; Arevalo Y
    Cureus; 2023 May; 15(5):e38797. PubMed ID: 37303316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature.
    Matsuda S; Yoshida S; Fujiki Y; Satomi H; Takeuchi T; Hirose Y; Makino S; Arawaka S
    Rheumatol Int; 2018 Apr; 38(4):689-696. PubMed ID: 29127573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful early introduction of mepolizumab for peripheral neuropathy with a peripheral circulatory disorder in a patient with myeloperoxidase anti-neutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis.
    Nishihara M; Hamaguchi M; Ikumi N; Nishiwaki A; Sugiyama K; Nagasawa Y; Tsuzuki H; Yoshizawa S; Tanikawa Y; Asatani S; Kobayashi H; Takei M; Kitamura N
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):354-359. PubMed ID: 33970058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.